<DOC>
	<DOCNO>NCT00577629</DOCNO>
	<brief_summary>The purpose study determine whether use high-dose chemotherapy , monoclonal antibody , target radioimmunotherapy slow progression disease patient high-risk Non-Hodgkin 's Lymphoma ( NHL ) .</brief_summary>
	<brief_title>Chemotherapy With Monoclonal Antibody Radioimmunotherapy High-Risk B-Cell Non-Hodgkins Lymphoma</brief_title>
	<detailed_description>This phase II efficacy trial patient untreated , high-risk , B-cell Non-Hodgkin 's Lymphoma . The study evaluate efficacy safety high-dose chemotherapy combine monoclonal antibody target radioimmunotherapy previously untreated patient high-risk NHL</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<mesh_term>Rituximab</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Iodine-131 anti-B1 antibody</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Untreated , biopsy proven Bcell nonHodgkin 's lymphoma Age &gt; /= 18 year No prior malignancy except adequately treat basal cell squamous cell skin cancer , situ cervical cancer , cancer patient diseasefree one year . The patient expose chemotherapy treat disease least 3 year prior study entry . Meet stag study laboratory test prior induction , consolidation radioimmunotherapy . Significant medical and/or psychiatric illness may compromise plan treatment ; Pregnant lactating ; HIVinfection . Patients follicular lymphoma grade 1 , 2 3A eligible trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>high risk non-hodgkins lymphoma</keyword>
	<keyword>NHL</keyword>
	<keyword>Bexxar</keyword>
	<keyword>high dose chemotherapy</keyword>
</DOC>